Colchicine in Patients With Acute Coronary Syndrome | Zendy

David Tong | Zendy; Stephen Quinn | Zendy; Arthur Nasis | Zendy; C. Hiew | Zendy; Philip RobertsThomson | Zendy; Heath Adams | Zendy; R. Sriamareswaran | Zendy; Nay Htun | Zendy; William Wilson | Zendy; Dion Stub | Zendy; W. van Gaal | Zendy; L. G. Howes | Zendy; Nicholas Collins | Zendy; A. Yong | Zendy; Ravinay Bhindi | Zendy; Robert Whitbourn | Zendy; A. Lee | Zendy; C. Hengel | Zendy; Kaleab Asrress | Zendy; Melanie Freeman | Zendy; John Amerena | Zendy; Amanda Wilson | Zendy; Jamie Layland | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Colchicine in Patients With Acute Coronary Syndrome

Author(s) -

David Tong,

Stephen Quinn,

Arthur Nasis,

C. Hiew,

Philip RobertsThomson,

Heath Adams,

R. Sriamareswaran,

Nay Htun,

William Wilson,

Dion Stub,

W. van Gaal,

L. G. Howes,

Nicholas Collins,

A. Yong,

Ravinay Bhindi,

Robert Whitbourn,

A. Lee,

C. Hengel,

Kaleab Asrress,

Melanie Freeman,

John Amerena,

Amanda Wilson,

Jamie Layland

Publication year - 2020

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.120.050771

Subject(s) - medicine , colchicine , acute coronary syndrome , cardiology , coronary heart disease , myocardial infarction

Inflammation plays a crucial role in clinical manifestations and complications of acute coronary syndromes (ACS). Colchicine, a commonly used treatment for gout, has recently emerged as a novel therapeutic option in cardiovascular medicine owing to its anti-inflammatory properties. We sought to determine the potential usefulness of colchicine treatment in patients with ACS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research